Potentially highly-conflicted PCAC meets this week on pop peptides, but no waivers

So-called wellness peptides are even more in the spotlight this week as the pharmacy compounding advisory committee or PCAC launches a series of meetings to evaluate restoration of compounding of these unproven peptide drugs. This committee is supposed to take FDA staff guidance into consideration as it decides what to recommend to the agency. Typically [ ] The post Potentially highly-conflicted…